Core Points - Cannara Biotech Inc. will release its financial results for the fiscal fourth quarter and fiscal year ended August 31, 2025, on November 24, 2025, at 7:00 a.m. ET [1] - The earnings webcast will be hosted by CEO Zohar Krivorot and CFO Nicholas Sosiak on the same day at 11:00 a.m. ET, featuring prepared remarks and a Q&A session [2] - Investors are encouraged to submit questions in advance via email, with priority given to those submitted before the session [3] Board Update - The company announced the passing of Jack M. Kay, a long-serving member of the Board of Directors, who contributed over five decades of leadership experience in the pharmaceutical sector [4][5] - Mr. Kay held several senior executive positions at Apotex Inc. and served in key leadership roles across various pharmaceutical and biotechnology organizations [5] - The company extends its condolences to Mr. Kay's family and expresses gratitude for his contributions [6] Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec that span over 1,650,000 sq. ft. [8] - The company has a potential annualized cultivation output of 100,000 kg, leveraging low electricity costs in Québec to produce affordable premium-grade cannabis [8]